GenSci120

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GenSci120, covering 2025-08-06 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults. [Phase 1]